Gastrointestinal Diseases: Clinical Trials

3,161 trials for Gastrointestinal Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1485 completed, 454 recruiting, 420 terminated, 348 unknown. 3161 Phase 1, 1136 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13161Completed 1485, Recruiting 454, Terminated 420, Unknown 348, Active not recruiting 192, Not yet recruiting 118, Withdrawn 116, Suspended 18, Enrolling by invitation 10
Phase 21136Completed 413, Recruiting 205, Unknown 177, Terminated 147, Active not recruiting 84, Withdrawn 50, Not yet recruiting 46, Suspended 8, Enrolling by invitation 6

Follow Gastrointestinal Diseases: new trials by email Literature Review of Gastrointestinal Diseases trials Research Report on Gastrointestinal Diseases

Trials (filtered) newest first · largest first

All 3,161 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Immunotherapy Treating GI Cancer
engineered immune cells - Cancer
Phase 1 / Phase 2Not yet recruitingShenzhen Geno-Immune Medical Institute1002027-06-012026-11-02
CCR5 Targeting Leronlimab in Combination With Hepatic Arterial Infusion Floxuridine and Systemic Therapy for the Treatment of Colorectal Cancer Liver Metastases, CHAMP Trial
Biopsy Procedure, Biospecimen Collection, Computed Tomography - Metastatic Colorectal Carcinoma, Metastatic Malignant Neoplasm in the Liver
Phase 1Not yet recruitingCity of Hope Medical Center362027-05-062026-09-25
LMT503 First-in-human SAD, MAD, and FE Study
LMT503, Placebo - Inflammatory Bowel Disease, Colitis, Ulcerative
Phase 1Not yet recruitingLmito Therapeutics Inc.722027-03-012026-09-01
Xylitol Use for Decolonization of C. Difficile in Patients With IBD
Xylitol, Placebo - Inflammatory Bowel Diseases, Clostridioides Difficile Infection
Phase 1Not yet recruitingBrigham and Women's Hospital992027-03-012026-11-18
A Safety Study of ST316 in Participants With Familial Adenomatous Polyposis (FAP).
ST316 IV - Familial Adenomatous Polyposis (FAP)
Phase 1Not yet recruitingSapience Therapeutics402027-01-042026-08-12
Outside the Cage (OTC) Robotic Esophagectomy
OTC MIE Esophagectomy - Esophageal Cancer
Phase 1Not yet recruitingCentre hospitalier de l'Université de Montréal (CHUM)312027-01-012026-03-18
Axatilimab + CAR-T for High-Risk Lymphoma
Axatilimab - Diffuse Large B Cell Lymphoma (DLBCL), Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma
Phase 1Not yet recruitingNorthside Hospital, Inc.292026-12-312026-10-16
Safety, Tolerability and PK of ATTO 1091 in Healthy Adult Volunteers and Patients With Ulcerative Colitis
ATTO-1091, Placebo - Ulcerative Colitis (UC)
Phase 1Not yet recruitingAttovia Therapeutics Inc962026-12-142026-09-15
A Study of DES-1357 in People With Deficient Mismatch Repair (dMMR)/Microsatellite Instability-High (MSI-H) Metastatic Colorectal Cancer (mCRC)
DES-1357 - Metastatic Colorectal Cancer (CRC)
Phase 1 / Phase 2Not yet recruitingD. E. Shaw Research, LLC882026-12-032026-09-08
COQ10 and Vitamin E for Off-Target Radiation Toxicity
Coenzyme Q10 Cap/Tab, Vitamin E Cap/Tab - Prostate Cancer, Uterine Cancer
Phase 1 / Phase 2Not yet recruitingUniversity of Nebraska2002026-12-012026-10-08
Ivonescimab and ADG126, Alone, and in Combination With Leucovorin and Fluorouracil or FOLFIRI Regimen for the Treatment of Microsatellite Stable Advanced/Metastatic Colorectal Cancer
Biospecimen Collection, Computed Tomography, Fluorouracil - Advanced Microsatellite Stable Colorectal Carcinoma, Metastatic Microsatellite Stable Colorectal Carcinoma
Phase 1Not yet recruitingCity of Hope Medical Center302026-12-012026-09-02
A Study of LG00313112 in Participants With Advanced Solid Malignancies Harboring a TP53 Y220C Mutation
LG00313112 - Ovarian Cancer, Small Cell Lung Cancer
Phase 1 / Phase 2Not yet recruitingLG Chem2502026-12-012026-08-07
TCR1188-ABC Cells in KRAS-mutated Cancers
TCR1188-ABC cells, Fludarabine + Cyclophosphamide combination, Tocilizumab - Cholangiocarcinoma, Colorectal Cancer
Phase 1RecruitingUniversity of Pennsylvania302026-12-012026-10-14
SND002 Cell Injection in Participants With Advanced Malignant Solid Tumors
SND002 Cell Injection - Colorectal Neoplasms, Stomach Neoplasms
Phase 1Not yet recruitingGuizhou Sinorda Pharmaceutical Co., Ltd.782026-12-012026-11-04
Study of Varsetatug Masetecan in Combination With Anti-Cancer Therapies in Colorectal Cancer
varsetatug masetecan, bevacizumab + 5-FU + leucovorin, bevacizumab - Colo-rectal Cancer
Phase 1 / Phase 2Not yet recruitingCytomX Therapeutics3682026-12-012026-10-28
A Study of LY4336619 in Adult Participants With Advanced Solid Tumors
LY4336619, Sofetabart Mipitecan (Sofe-M) - Endometrial Neoplasms, Ovarian Neoplasms
Phase 1Not yet recruitingEli Lilly and Company3702026-12-012026-11-10
SumMET: Study of [225Ac]Ac-FL-261 in Participants With Solid Tumors Overexpressing c-MET
[225Ac]Ac-FL-261 - Solid Tumor, NSCLC
Phase 1 / Phase 2RecruitingFull-Life Technologies UK Limited2082026-12-012026-11-16
A Study to Evaluate the Safety and Activity of GDC-7035 With Anti-Cancer Therapies in Participants With KRAS G12D-Mutated Unresectable Advanced or Metastatic Colorectal Cancer or Pancreatic Ductal Adenocarcinoma
GDC-7035, Panitumumab, mFOLFOX6 - Colorectal Neoplasms, Pancreatic Ductal Adenocarcinoma
Phase 1Not yet recruitingGenentech, Inc.3882026-11-302026-11-10
A Study of BMS-986548 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
BMS-986548, Cetuximab - Advanced Solid Malignancies
Phase 1 / Phase 2Not yet recruitingBristol-Myers Squibb1712026-11-302026-11-16
A Study of GSK5864399 Administered Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumours
GSK5864399 - Solid Tumours
Phase 1 / Phase 2Not yet recruitingGlaxoSmithKline1552026-11-252026-11-18

Showing 20 of 3161. Sign in to see all of them.

Narrower conditions

Colorectal Neoplasms (1249)  ·  Stomach Neoplasms (658)  ·  Carcinoma, Non-Small-Cell Lung (496)  ·  Colonic Neoplasms (431)  ·  Esophageal Neoplasms (381)  ·  Pancreatic Neoplasms (381)  ·  Breast Neoplasms (370)  ·  Ovarian Neoplasms (314)  ·  Rectal Neoplasms (312)  ·  Neoplasms (278)  ·  Neoplasm Metastasis (258)  ·  Lung Neoplasms (240)  ·  Melanoma (235)  ·  Squamous Cell Carcinoma of Head and Neck (210)  ·  Colitis, Ulcerative (185)

Broader conditions

Digestive System Diseases (3144)  ·  Digestive System Neoplasms (2334)  ·  Neoplasms by Site (2323)  ·  Gastrointestinal Neoplasms (2217)  ·  Intestinal Diseases (2193)  ·  Neoplasms (2127)  ·  Colonic Diseases (1715)  ·  Intestinal Neoplasms (1601)  ·  Rectal Diseases (1497)  ·  Neoplasms by Histologic Type (873)  ·  Stomach Diseases (726)  ·  Neoplasms, Glandular and Epithelial (700)  ·  Respiratory Tract Diseases (681)  ·  Lung Diseases (668)

Interventions

Fluorouracil (185)  ·  Oxaliplatin (180)  ·  pembrolizumab (166)  ·  Capecitabine (152)  ·  Irinotecan (141)  ·  Leucovorin (133)  ·  Cetuximab (132)  ·  Bevacizumab (124)  ·  Cisplatin (95)  ·  Paclitaxel (87)  ·  Nivolumab (82)  ·  Radiotherapy (78)  ·  Cyclophosphamide (69)  ·  Carboplatin (65)  ·  Gemcitabine (60)

Sponsors

National Cancer Institute (NCI) (124)  ·  M.D. Anderson Cancer Center (47)  ·  Pfizer (47)  ·  GlaxoSmithKline (45)  ·  AstraZeneca (38)  ·  Novartis Pharmaceuticals (38)  ·  Memorial Sloan Kettering Cancer Center (31)  ·  Mayo Clinic (29)  ·  Eli Lilly and Company (27)  ·  Bristol-Myers Squibb (25)  ·  City of Hope Medical Center (22)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (21)  ·  Incyte Corporation (20)  ·  Merck Sharp & Dohme LLC (20)  ·  Roswell Park Cancer Institute (20)

Countries

United States (1708)  ·  China (463)  ·  South Korea (262)  ·  Spain (237)  ·  United Kingdom (220)  ·  Australia (215)  ·  Canada (209)  ·  France (204)  ·  Germany (162)  ·  Japan (158)  ·  Netherlands (136)  ·  Belgium (129)  ·  Italy (126)  ·  Taiwan (95)  ·  Denmark (65)

Top investigators

Amy Lightner, MD (7)

Results publications

PMID 40056080, PMID 17560413, PMID 18590344, PMID 18590345, PMID 22607579, PMID 26808342, PMID 27490698, PMID 28735965, PMID 30277655, PMID 31527168, PMID 34017343, PMID 35219300, PMID 35362047, PMID 35537408, PMID 36897458, PMID 36977960, PMID 37082579, PMID 37496366, PMID 37590355, PMID 37788341, PMID 37917289, PMID 37934000, PMID 38267790, PMID 38580386, PMID 39462179, PMID 40443562, PMID 41044356, PMID 42201333, PMID 42580817, PMID 10235156, PMID 10496568, PMID 10628373, PMID 10655252, PMID 10811496, PMID 11127145, PMID 11573045, PMID 11705489, PMID 11743810, PMID 11870157, PMID 11919232, PMID 11919233, PMID 12049861, PMID 12196376, PMID 12393999, PMID 12454110, PMID 12528778, PMID 12576903, PMID 12607634, PMID 12663720, PMID 12680184

NIH funding

2023 (47), 2016 (28), 2025 (27), 2017 (24), 2019 (24), 2015 (19), 2018 (17), P30CA033572 (13), 2009 (11), 2014 (10), 2008 (9), P30CA016672 (9), UM1CA186690 (7), P30CA015083 (6), P30CA016056 (6)